As on 13-Aug-2024 IST
₹11,639.05
₹11,649.90
₹11,699.00
₹11,390.00
26,482
₹3,400.00 - 11,845.95
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
---|---|---|---|---|---|---|---|
Neuland Lab
| 116.99 | 42.13 | 60.81 | 179.30 | 89.62 | 90.00 | 44.60 |
BSE Healthcare
| 30.05 | 6.86 | 18.26 | 46.79 | 16.31 | 26.45 | 12.81 |
BSE Mid Cap
| 26.89 | -1.61 | 13.94 | 53.62 | 26.75 | 27.88 | 17.84 |
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|
---|---|---|---|---|---|---|---|
Neuland Lab
| 217.43 | 7.89 | 41.71 | 161.53 | -12.17 | -48.23 | -13.51 |
BSE Mid Cap
| 45.53 | 1.38 | 39.18 | 19.87 | -3.05 | -13.31 | 48.13 |
BSE Healthcare
| 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 | 0.49 |
Stock
|
Peer Median
|
||
---|---|---|---|
Please wait... |
Stock
|
Peer Median
|
||
---|---|---|---|
Please wait... |
The total asset value of Neuland Laboratories Ltd stood at ₹ 1,833 Cr as on 30-Jun-24
The share price of Neuland Laboratories Ltd is ₹11,481.55 (NSE) and ₹11,466.25 (BSE) as of 13-Aug-2024 IST. Neuland Laboratories Ltd has given a return of 89.62% in the last 3 years.
Neuland Laboratories Ltd has a market capitalisation of ₹ 14,711 Cr as on 13-Aug-2024. As per Value Research classification, it is a Mid Cap company.
The P/B ratio of Neuland Laboratories Ltd is 10.66 times as on 13-Aug-2024, a 205% premium to its peers’ median range of 3.50 times.
The P/E ratio of Neuland Laboratories Ltd is 43.77 times as on 13-Aug-2024, a 8% discount to its peers’ median range of 47.46 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Neuland Laboratories Ltd and enter the required number of quantities and click on buy to purchase the shares of Neuland Laboratories Ltd.
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
The promoters of Neuland Laboratories Ltd are RAMAMOHAN RAO DAVULURI and DAVULURI VIJAYA RAO. They collectively own 26.37 per cent of the total equity. The chairman of the company is Davuluri Rama Mohan Rao
There is no promoter pledging in Neuland Laboratories Ltd.
Some of the close peers are:
Company | Market Cap(₹ Cr) |
---|---|
16,256
|
|
1,28,227
|
|
11,208
|
|
8,248
|
Neuland Laboratories Ltd. | Ratios |
---|---|
Return on equity(%)
|
26.54
|
Operating margin(%)
|
26.09
|
Net Margin(%)
|
20.36
|
Dividend yield(%)
|
0.12
|
Yes, TTM profit after tax of Neuland Laboratories Ltd was ₹336 Cr.
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics,... cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India. Read more